MLchartDataset catalogue

anti-Senl-h19 CAR T cells

Term · Oncology and biomedicine · MLC-T-ONC-011084

A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the human tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, anti-Senl-h19 CAR T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies.

Table 1. Record
IdentifierMLC-T-ONC-011084
FieldOncology and biomedicine
SynonymsSenl-h19 CAR T cells; Senl-h19 CAR-T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011084",
  "term": "anti-Senl-h19 CAR T cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the human tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, anti-Senl-h19 CAR T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies.",
  "synonyms": [
    "Senl-h19 CAR T cells",
    "Senl-h19 CAR-T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-senl-h19-car-t-cells/"
}

Record 2,219 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.